Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.91)
# 1,564
Out of 4,876 analysts
2
Total ratings
100%
Success rate
42.25%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $8.24
Upside: +21.36%